AMAleksandra Moździerz

Aleksandra Moździerz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aleksandra Moździerz has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Jerzy Stojko

    Department of Toxicology, Toxicological Analysis and Bioanalysis, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland

    9 shared publications
  • Anna Rzepecka-Stojko

    Department of Drug and Cosmetics Technology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland

    8 shared publications
  • Magdalena Kurkiewicz

    Department of Toxicology, Toxicological Analysis and Bioanalysis, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland

    4 shared publications
  • Agata Kabała-Dzik

    Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Ostrogórska 30, 41-200 Sosnowiec, Poland

    3 shared publications
  • Ewa Buszman

    Department of Pharmaceutical Chemistry, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska 4, 41-200 Sosnowiec, Poland

    3 shared publications
  • Robert Kubina

    Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland

    3 shared publications

Latest Publications

  • Open Access

    The Role of Autophagy in Cancer Evolution and Prognosis, Highlighting Its Role in PCa and Its Interaction with Apoptosis and Epigenetic Regulation by miRNAs

    by Magdalena Kurkiewicz, Aleksandra Moździerz, Anna Rzepecka-Stojko, Jerzy Stojko

    Background: Autophagy is a process that diversely impacts the stages of both tumor initiation and progression. Elucidating the molecular mechanisms underlying autophagy and its role in tumorigenesis is a key component of anticancer strategies in both prostate cancer and other malignancies. Because advanced prostate cancer frequently exploits enhanced autophagy as a defense mechanism against therapy-induced stress (e.g., from abiraterone), the pharmacological modulation of miRNA levels presents a tremendous opportunity to block the tumor’s escape route and overcome drug resistance. Methods: A comprehensive literature review was conducted to evaluate the molecular pathways determining cancer cell survival and death. The analysis focused on the dual nature of autophagy (functioning as a ‘double-edged sword’) within the tumor microenvironment, microRNA (miRNA) regulatory networks, and the efficacy of synergistic therapeutic strategies in overcoming treatment resistance. Results: The primary focus of this paper is the dual and complex role of autophagy, which serves, on the one hand, as a cellular protective shield against metabolic stress—thereby facilitating metastasis—and, on the other hand, as a potential pathway leading to autophagic cell death. The progression of this crucial process is regulated by intricate interactions (crosstalk) with apoptotic pathways, mediated by Bcl-2 family proteins, key kinases (such as mTOR, JNK, and DAPK), and transcription factors, such as p53. Furthermore, the autophagic machinery is precisely regulated by specific miRNA molecules (e.g., miR-21, miR-141, and miR-375). These not only act as crucial intracellular modulators of autophagy but also serve as promising circulating biomarkers, enabling the monitoring of this process’s activity throughout disease progression. Conclusions: Autophagy, and in particular its modulation via miRNA signaling networks, represents a major and highly promising translational target. By directly impairing this autophagic survival mechanism, ‘double-hit’ combination therapies—integrating autophagy inhibitors (such as hydroxychloroquine or VPS34 inhibitors) with standard antiandrogen or cytotoxic agents—demonstrate promising preclinical potential in overcoming treatment resistance and favorably modulating the immune microenvironment in advanced prostate cancer.

  • Open Access

    Survival in Men Treated for Lung Cancer: A Single-Center Retrospective Cohort Study in Poland

    by Magdalena Królikowska-Jerużalska, Magdalena Kurkiewicz, Aleksandra Moździerz, Anna Rzepecka-Stojko, Jerzy Stojko

    Introduction: Lung cancer remains the leading cause of cancer-related mortality among men in Poland. Prognosis is generally poor, largely due to late diagnosis at advanced stages and the aggressive biological nature of the disease. Aim: This study aimed to evaluate the effectiveness of various treatment modalities and determine their impact on overall survival in male patients diagnosed with small-cell (SCLC) and non-small-cell lung cancer (NSCLC). Methods: This retrospective cohort study analyzed 1431 men (mean age: 61.5 years) treated at the Katowice Oncology Center in Poland between 2002 and 2012. Overall survival was assessed using the Kaplan–Meier method and multivariable Cox proportional hazards regression. Evaluated prognostic factors included clinical stage, surgical intervention (partial or total lung resection), first-line treatment regimen, and the number of treatment cycles. Results: Survival probabilities declined progressively with advancing clinical stage for both SCLC and NSCLC. Patients who underwent surgical resection demonstrated significantly longer survival compared to non-surgically treated patients (p < 0.001). Furthermore, combined radiochemotherapy yielded superior therapeutic outcomes compared to chemotherapy alone. In the non-surgical NSCLC cohort, first-line treatment with platinum derivatives combined with gemcitabine resulted in the highest 1-year survival rate compared to other pharmacological schemes. Discussion: The high mortality observed within the first 12 months post diagnosis reflects the late-stage presentation common during the study period. The findings align with established oncological principles, confirming that surgical resection and multimodal therapies offer the greatest survival advantages for eligible patients. Conclusions: Survival rates for both SCLC and NSCLC are overwhelmingly dictated by early diagnosis and the feasibility of surgical resection. Improving long-term outcomes depends heavily on implementing effective lung cancer screening programs to detect the disease at operable stages and utilizing optimized combined treatment protocols.

  • Top Cited Papers
    Open Access

    Chrysin: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Potential

    by Magdalena Kurkiewicz, Aleksandra Moździerz, Anna Rzepecka-Stojko, Jerzy Stojko

    Flavonoids constitute a broad class of naturally occurring chemical compounds classified as polyphenols, widely present in various plants, fruits, and vegetables. They share a common flavone backbone, composed of two aromatic rings (A and B) connected by a three-carbon bridge forming a heterocyclic ring (C). One representative flavonoid is chrysin, a compound found in honey, propolis, and passionflower (Passiflora spp.). Chrysin exhibits a range of biological activities, including antioxidant, anti-inflammatory, anticancer, neuroprotective, and anxiolytic effects. Its biological activity is primarily attributed to the presence of hydroxyl groups, which facilitate the neutralization of free radicals and the modulation of intracellular signaling pathways. Cellular uptake of chrysin and other flavonoids occurs mainly through passive diffusion; however, certain forms may be transported via specific membrane-associated carrier proteins. Despite its therapeutic potential, chrysin’s bioavailability is significantly limited due to poor aqueous solubility and rapid metabolism in the gastrointestinal tract and liver, which reduces its systemic efficacy. Ongoing research aims to enhance chrysin’s bioavailability through the development of delivery systems such as lipid-based carriers and nanoparticles.


  • Open Access

    Analysis of mercury content in fish and its impact on human health in the context of omega-3 and omega-6 fatty acid (DHA, EPA) supplementation derived from fish oil

    by Aleksandra Moździerz, Magdalena Kurkiewicz, Anna Rzepecka-Stojko, Jerzy Stojko

    Fish oils, such as cod liver oil or shark liver oil, are a valuable source of essential omega-3 unsaturated fatty acids (EFAs) (mainly DHA and EPA) and vitamins A and D, which are crucial for the proper functioning of the body, including neurological development, vision and the cardiovascular system. Due to the low consumption of fish in Poland, dietary supplements containing these oils have gained popularity. However, a significant problem is the potential contamination of fish and fish products with heavy metals, especially mercury. Mercury, mainly in the form of methylmercury, accumulates in aquatic organisms, especially in predatory and long-lived fish, due to environmental pollution. Methylmercury is highly toxic. It penetrates the blood-brain and blood-placenta barriers, posing a risk of neurotoxicity, developmental problems and a negative impact on the circulatory, immune, urinary and hormonal systems. The applicable regulations (e.g. Commission Regulation (EC) No. 629/2008, ICH Q3D guidelines) specify permissible levels of mercury in food, dietary supplements and medicinal products, with the standards for supplements being more stringent than for fish meat. Studies have shown that commercially available fish oil supplements usually contain mercury in amounts below the established limits, making them safe for consumption. Nevertheless, due to the dynamic development of the market and the lack of mandatory control before placing on the market, the need for constant quality monitoring and possible tightening of legal requirements for dietary supplements is postulated.


  • Open Access

    Correction: Rzepecka-Stojko, A., et al. Polyphenols from Bee Pollen: Structure, Absorption, Metabolism and Biological Activity. Molecules 2015, 20, 21732–21749

    by Anna Rzepecka-Stojko, Jerzy Stojko, Anna Kurek-Górecka, Michał Górecki, Agata Kabała-Dzik, Robert Kubina, Aleksandra Moździerz, Ewa Buszman

    The authors wish to make the following corrections to this paper:


  • Open Access

    Polyphenols from Bee Pollen: Structure, Absorption, Metabolism and Biological Activity

    by Anna Rzepecka-Stojko, Jerzy Stojko, Anna Kurek-Górecka, Michał Górecki, Agata Kabała-Dzik, Robert Kubina, Aleksandra Moździerz, Ewa Buszman

    Bee pollen constitutes a natural source of antioxidants such as phenolic acids and flavonoids, which are responsible for its biological activity. Research has indicated the correlation between dietary polyphenols and cardioprotective, hepatoprotective, anti-inflammatory, antibacterial, anticancerogenic, immunostimulating, antianaemic effects, as well as their beneficial influence on osseous tissue. The beneficial effects of bee pollen on health result from the presence of phenolic acids and flavonoids which possess anti-inflammatory properties, phytosterol and linolenic acid which play an anticancerogenic role, and polysaccharides which stimulate immunological activity. Polyphenols are absorbed in the alimentary tract, metabolised by CYP450 enzymes, and excreted with urine and faeces. Flavonoids and phenolic acids are characterised by high antioxidative potential, which is closely related to their chemical structure. The high antioxidant potential of phenolic acids is due to the presence and location of hydroxyl groups, a carboxyl group in the immediate vicinity of ortho-diphenolic substituents, and the ethylene group between the phenyl ring and the carboxyl group. As regards flavonoids, essential structural elements are hydroxyl groups at the C5 and C7 positions in the A ring, and at the C3′ and C4′ positions in the B ring, and a hydroxyl group at the C3 position in the C ring. Furthermore, both, the double bond between C2 and C3, and a ketone group at the C4 position in the C ring enhance the antioxidative potential of these compounds. Polyphenols have an ideal chemical structure for scavenging free radicals and for creating chelates with metal ions, which makes them effective antioxidants in vivo.


  • Open Access

    Caffeic Acid Phenethyl Ester and Ethanol Extract of Propolis Induce the Complementary Cytotoxic Effect on Triple-Negative Breast Cancer Cell Lines

    by Anna Rzepecka-Stojko, Agata Kabała-Dzik, Aleksandra Moździerz, Robert Kubina, Robert D. Wojtyczka, Rafał Stojko, Arkadiusz Dziedzic, Żaneta Jastrzębska-Stojko, Magdalena Jurzak, Ewa Buszman, et al.

    Chemotherapy of breast cancer could be improved by bioactive natural substances, which may potentially sensitize the carcinoma cells’ susceptibility to drugs. Numerous phytochemicals, including propolis, have been reported to interfere with the viability of carcinoma cells. We evaluated the in vitro cytotoxic activity of ethanol extract of propolis (EEP) and its derivative caffeic acid phenethyl ester (CAPE) towards two triple-negative breast cancer (TNBC) cell lines, MDA-MB-231 and Hs578T, by implementation of the MTT and lactate dehydrogenase (LDH) assays. The morphological changes of breast carcinoma cells were observed following exposure to EEP and CAPE. The IC50 of EEP was 48.35 µg∙mL−1 for MDA-MB-23 cells and 33.68 µg∙mL−1 for Hs578T cells, whereas the CAPE IC50 was 14.08 µM and 8.01 µM for the MDA-MB-231 and Hs578T cell line, respectively. Here, we report that propolis and CAPE inhibited the growth of the MDA-MB-231 and Hs578T lines in a dose-dependent and exposure time-dependent manner. EEP showed less cytotoxic activity against both types of TNBC cells. EEP and, particularly, CAPE may markedly affect the viability of breast cancer cells, suggesting the potential role of bioactive compounds in chemoprevention/chemotherapy by potentiating the action of standard anti-cancer drugs.


  • Open Access

    Incidence of Melanoma and Non-Melanoma Skin Cancer in the Inhabitants of the Upper Silesia, Poland

    by Małgorzata Juszko-Piekut, Aleksandra Moździerz, Zofia Kołosza, Magdalena Królikowska-Jerużalska, Paulina Wawro-Bielecka, Grażyna Kowalska-Ziomek, Dorota Olczyk, Jerzy Stojko

    Incidence of Melanoma and Non-Melanoma Skin Cancer in the Inhabitants of the Upper Silesia, Poland | InTechOpen, Published on: 2013-04-17. Authors: Małgorzata Juszko-Piekut, Aleksandra Moździerz, Zofia Kołosza, et


    • 1 January 2012
      • Vol. 69  (10) , 833-6

    [The role of nicotine as a modulator of the activity of acid phosphotase and cathepsin D and L in the liver and kidney of mice].

    by Aleksandra Moździerz, Anna Rzepecka-Stojko, Małgorzata Juszko-Piekut, Dorota Olczyk, Jerzy Stojko, Włodzimierz Mierzwa, Wioleta Kobiela

    To our knowledge, no reports on the impact of nicotine on the enzyme activity of the lysosomal system have been published yet. The study which is reported here is probably one of the first analyses of the models of lysosomal hydrolases of the liver and kidney of experimental mice which were exposed to various doses of nicotine. The aim of our experimental study was to analyze the impact of nicotine administered for 4 or 8 days in the dosage of 12 and 20 mg/kg body weight, respectively, on the activity of acid phosphatase and cathepsins D and L, i.e. lysosomal hydrolases of the liver and kidney of mice. The experimental group constituted 60 Swiss male mice, aged 8-9 weeks, of average body weight of 23.4 +/- 1.2 grams. We came to the following conclusions after the completion of the experimental study and laboratory analyses: - nicotine injected once a day in the dosage of 12 mg and 20 mg/kg body weight for 4 and 8 days caused a significant increase in the activity of acid phosphatase, and cathepsins D and L in the liver and kidney of the studied mice. The range of observed changes was related to the organ, the dosage and administration time; - the increase in the activity of studied enzymes after administering nicotine may indicate that the alkaloid exhibits destabilizing activity in lysosomal membranes of the liver and kidney cells, therefore it may affect metabolic pathways of those organs.